Advertisement

Related Videos

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Amit Sanyal, MD: A Clinician’s Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Advertisement

Advertisement




Oct
06
Today In Oncology
Autonomous AI Triaged Urgent Suspected Skin Cancer Referrals in Real-World Implementation Study
ER-Positive HER2-Negative Advanced Breast Cancer: Giredestrant Plus Everolimus
Immune Cell Dysfunction Not Absence Defines Nonmelanoma Skin Cancer in Immunosuppressed Patients
Wildfire-Related Fine Particulate Matter Linked to Higher Mortality in Older Patients With Lung Cancer
Global Gaps in Cancer-Control Expenditure Data Identified
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo